<DOC>
	<DOCNO>NCT01285843</DOCNO>
	<brief_summary>This monocentric , prospective , randomized clinical survey verify periprosthetic remodelling brought either AMIStem Quadra femoral component equivalent .</brief_summary>
	<brief_title>Periprosthetic Bone Mineral Density After Total Hip Arthroplasty Performed Through Minimally Invasive Anterior Approach ( AMIS ) With Either AMIStem Quadra Femoral Component</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Necrosis</mesh_term>
	<mesh_term>Hip Dislocation</mesh_term>
	<mesh_term>Hip Dislocation , Congenital</mesh_term>
	<criteria>Patients willing able provide write informed consent participation study . Written informed consent must obtain prior patient 's surgery . Patients present disease meet indication use Medacta implant define study ( onlabel use ( enclosure 2 ) ) . Patients must willing comply pre postoperative evaluation schedule . Patients one low limb arthroplasty Patient metabolic bone disease , use steroid drug affect bone metabolism Patients osteoporosis ( preop Tscore &lt; 2,5 ) Patients significant comorbidities Patients hip knee arthroplasty Patients restrict mobility Patient severe hip contracture Those one medical condition identify contraindication define label Medacta implant use study</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2011</verification_date>
</DOC>